Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriques, Gisela, Phommasone, Koukeo, Tripura, Rupam, Peto, Thomas J., Raut, Shristi, Snethlage, Coco, Sambo, Im, Sanann, Nou, Nguon, Chea, Adhikari, Bipin, Pongvongsa, Tiengkham, Imwong, Mallika, von Seidlein, Lorenz, Day, Nicholas P., White, Nicholas J., Dondorp, Arjen M., Newton, Paul, Ley, Benedikt, Mayxay, Mayfong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013858/
https://www.ncbi.nlm.nih.gov/pubmed/29929514
http://dx.doi.org/10.1186/s12936-018-2390-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013858/
https://www.ncbi.nlm.nih.gov/pubmed/29929514
http://dx.doi.org/10.1186/s12936-018-2390-6

Ejemplares similares